PeptideStack
5.2kquestions
20kanswers
220users

Why did two ERP lots of mazdutide differ on content assay?

Asked 22 Jan 2025Modified 18 months agoViewed 1.6k times
2

Setup, so nobody has to ask: ERP · mazdutide.

I noticed this today and I have not touched anything since, in case the state is diagnostic.

I have not discarded anything yet, so a test is still possible if that is the recommendation.

Should I be treating this as a failure or as noise?

batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
content-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

438 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

436 questions
shareeditfollowflag
SB
askedsamir_bennani13k1822 Jan 2025
5This matches what I was told by a laboratory, for whatever that is worth. – tabular_nums 5 months ago
6Minor: the trial name is hyphenated in the original publication. – vialroom 6 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 1.6k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.